Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Guiqiang Wang and Hong Zhao.
Guiqiang Wang
Connection Strength
1.599
Hong Zhao
  1. The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive. Infect Dis Poverty. 2021 Mar 31; 10(1):45.
    View in: PubMed
    Score: 0.937
  2. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 08; 21(1):495.
    View in: PubMed
    Score: 0.222
  3. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 05; 21(1):488.
    View in: PubMed
    Score: 0.221
  4. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May; 55(5):105954.
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.